Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01EXL
|
|||
| Former ID |
DIB001732
|
|||
| Drug Name |
RNF43-721
|
|||
| Synonyms |
RNF43-721/Montanide ISA51; Peptide vaccine (subcutaneous, colorectal cancer), Tokyo Women's Medical College
Click to Show/Hide
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 2 | [1] | |
| Company |
Vaccinogen
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | RING finger protein 43 (RNF43) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer. Exp Ther Med. 2011 Jan-Feb; 2(1): 73-79. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.